news

As the global population ages, the demand for arrhythmia diagnosis and treatment continues to rise. Combined with ongoing advances in minimally invasive medical technologies, these factors are driving a new wave of growth and technological transformation in the cardiac electrophysiology (EP) ablation market.

From conventional radiofrequency (RF) and cryoablation to the rapid commercialization of pulsed field ablation (PFA), competition is evolving beyond individual energy modalities toward integrated systems combining high-density mapping, 3D navigation, real-time imaging, and precise energy control. As the industry moves toward 2027, competitive differentiation will increasingly depend not only on advances in ablation technology, but also on system-wide precision, safety, and reliability.

Dual Growth Drivers: Global Electrophysiology and PFA Markets

1. Rapid PFA Market Expansion: Projected to Reach US$6.44 Billion by 2031

According to Mordor Intelligence’s 2026 report, the global pulsed field ablation (PFA) market is projected to grow from US$2.02 billion in 2026 to US$6.44 billion by 2031, representing a compound annual growth rate (CAGR) of 26.1%. This strong growth outlook highlights the significant potential of next-generation non-thermal ablation technologies.

PFA delivers microsecond-scale, high-voltage electrical pulses to induce irreversible electroporation in targeted cells. Compared with conventional thermal ablation, this approach has the potential to reduce thermal injury to certain surrounding tissues while improving procedural efficiency.

Clinical adoption is also accelerating. According to a 2025 survey conducted by the European Heart Rhythm Association (EHRA), PFA accounted for approximately 49% of first-time atrial fibrillation (AF) ablation procedures reported by respondents, reflecting its growing role in pulmonary vein isolation (PVI). Note: Mordor Intelligence's PFA market estimates include cardiovascular and certain non-cardiac applications and are not limited to cardiac electrophysiology ablation.

2.Steady Growth in the Global EP Market Drives Next-Generation Ablation Platforms

The rapid expansion of PFA is supported by the sustained growth of the broader electrophysiology industry.

• ● Cardiac Ablation Market: According to Global Market Insights, the global cardiac ablation market is projected to grow from US$6.8 billion in 2026 to US$20 billion by 2035, at a CAGR of 12.8%.

● Overall Electrophysiology Market: MarketsandMarkets forecasts that the global electrophysiology market, encompassing ablation, diagnostic, and mapping equipment, will expand from US$12.55 billion in 2025 to US$21.72 billion by 2030, representing a CAGR of 11.6%.

Global MedTech Leaders Advance Multi-Energy and Integrated Ablation Platforms

Rather than a complete transition to a single ablation modality, the market is moving toward a future in which multiple energy technologies coexist within increasingly integrated treatment platforms. Four of the world's leading electrophysiology device manufacturers are accelerating their development of next-generation ablation solutions:

• ● Boston Scientific： Building on its FARAPULSE platform, the company continues to advance its next-generation FARAWAVE Ultra technology while expanding its focus on intracardiac echocardiography (ICE) and integrated imaging capabilities.
  ● Medtronic：Through PulseSelect, Affera, and Sphere-9, Medtronic is strengthening the integration of dual-energy RF/PFA ablation and high-density mapping technologies.
  ● Johnson & Johnson MedTech (Biosense Webster)：By combining VARIPULSE Pro, dual-energy ablation technologies, and the CARTO 3 navigation platform, the company is advancing precise target localization and integrated treatment workflows.
  ● Abbott：With its Volt PFA system, TactiFlex Duo, and EnSite X, Abbott is expanding its capabilities in multi-energy ablation and 3D electroanatomical mapping.

Three Key Technology Trends: From Ablation Energy to Integrated Treatment Systems

As leading medical device manufacturers continue to advance their platforms, competition across the electrophysiology industry from 2027 to 2035 is expected to center on three major technology trends：

1. Advancing Dual-Energy RF/PFA Ablation Platforms

Dual-energy ablation, which integrates pulsed field ablation (PFA) and radiofrequency (RF) technologies, is emerging as an important direction for next-generation electrophysiology systems. By allowing physicians to select between RF and PFA based on clinical needs and target tissue characteristics, these platforms provide greater flexibility in treatment planning and energy delivery. At the same time, they introduce increasingly demanding engineering requirements for high-voltage pulse transmission, electrical isolation, and multi-channel signal integration.

2. Integrating High-Density Mapping and 3D Navigation

The integration of high-density electroanatomical mapping (HD Mapping), 3D catheter navigation, and intracardiac echocardiography (ICE) is helping improve target localization, procedural guidance, and real-time visualization during ablation procedures. As these technologies become more closely integrated, high-density interconnects, low-noise transmission, and signal integrity are becoming increasingly critical to system performance.

3. Miniaturization and System Integration Drive Supply Chain Innovation

Next-generation electrophysiology systems are evolving toward greater functionality and higher levels of integration within increasingly compact designs. For medical device manufacturers, maintaining high-voltage insulation, signal isolation, electromagnetic interference (EMI) control, and reliable connectivity within severely constrained spaces has become a critical engineering challenge.

Enabling Next-Generation Electrophysiology Systems Through Precision Interconnect Technology

In next-generation electrophysiology systems, interconnect technology is no longer simply a component-level consideration. It plays a fundamental role in overall system performance, electrical safety, and long-term product reliability.

• ● High-Voltage Pulse Withstand Capability: PFA systems operate with kilovolt (kV)-level pulses and microsecond (µs)-scale pulse durations, placing stringent demands on connector insulation design, transient voltage withstand capability, and transmission reliability.
• ● Precision Signal Isolation: In high-density mapping systems, multi-channel signal configurations and low-noise transmission are essential engineering considerations for accurate electroanatomical mapping.

• With extensive expertise in medical-grade connectors, precision contacts, and customized cable assemblies, NEXTRON continues to focus on evolving interconnect requirements across electrophysiology applications, including RF, cryoablation, and PFA.

  Building on its expertise in customized 2,000–5,000 VAC high-voltage interconnect solutions, NEXTRON combines high-voltage insulation design, material selection, mechanical miniaturization, and precision manufacturing capabilities. By incorporating relevant design and verification practices with reference to applicable standards, including IEC 60664-4, NEXTRON addresses the evolving electrical safety and reliability requirements of next-generation medical equipment.

  Supported by its ISO 13485 medical device quality management system and customized engineering capabilities, NEXTRON works with medical device manufacturers across product development, engineering validation, and volume production, providing interconnect solutions tailored to diverse system requirements.

  Looking ahead, as PFA adoption accelerates and multi-energy ablation platforms continue to evolve, NEXTRON remains committed to advancing its high-voltage and high-density interconnect technologies. Through customized engineering, precision manufacturing, and integrated development capabilities, NEXTRON strives to be a trusted precision interconnect partner for medical device manufacturers worldwide.

  From precision energy delivery to reliable connectivity, NEXTRON enables the next generation of electrophysiology innovation through advanced interconnect technology.

• References
• ● European Heart Rhythm Association — Pulsed Field Ablation Survey, Europace
• ● Boston Scientific — Electrophysiology Market & Technology Outlook
• ● U.S. FDA — TactiFlex Duo Ablation Catheter Approval, September 2026
• ● Mordor Intelligence — Pulsed Field Ablation Market, 2026–2031
• ● Global Market Insights — Cardiac Ablation Market, 2026–2035
• ● MarketsandMarkets — Electrophysiology Market, Global Forecast to 2030
• ● European Heart Rhythm Association — Pulsed Field Ablation Survey, 2025